Supplements

Confusion over the rules governing drug compounding has been an issue for many years. However, concerns about the safety and quality of compounded sterile products (CSPs), spurred by an outbreak of fungal meningitis infections that occurred in October 2012, have led to a fundamental change in the regulatory framework.
In spring and summer 2014, internationally renowned physicians, nurses, pharmacists, payers, basic scientists, and other members of the healthcare team involved in the care of patients with solid tumors and hematologic malignancies gathered at the Annual Meeting of the American Society of Clinical Oncology and the 19th Congress of the European Hematology Association
In spring and summer 2014, internationally renowned physicians, nurses, pharmacists, payers, basic scientists, and other members of the healthcare team involved in the care of patients with solid tumors and hematologic malignancies gathered at the Annual Meeting of the American Society of Clinical Oncology and the 19th Congress of the European Hematology Association
Building Bridges to Con­quer Cancer, the theme of the 2013 annual American Society of Clinical Oncology (ASCO) meeting held in Chicago, IL, is an appropriate goal of all healthcare practitioners who specialize in hematology/oncology, including postgraduate year 2 (PGY-2) oncology pharmacy residents.
Building Bridges to Con­quer Cancer, the theme of the 2013 annual American Society of Clinical Oncology (ASCO) meeting held in Chicago, IL, is an appropriate goal of all healthcare practitioners who specialize in hematology/oncology, including postgraduate year 2 (PGY-2) oncology pharmacy residents.
In this issue of Conquering the Cancer Care Continuum you will learn about a hot topic that most cancer centers and oncologists are struggling to make a reality: survivorship care plans for all cancer survivors at the end of (acute) treatment, coupled with a comprehensive treatment summary. There is good news and bad news to share with you about the need for this document.
Cancer remains the second leading cause of death in the United States, and the American Cancer Society estimates there are approximately 13.7 million cancer survivors in the United States, with 18 million projected by 2022.
In our community cancer center, identifying and diagnosing a second malignancy in a patient like LM is highly unusual. However, as one of a constellation of known survivorship issues in patients treated with chemotherapy and/or radiation therapy, we teach pharmacy students and medical residents training at our site to internalize a philosophy of “pattern recognition.”
In 2005, the Institute of Medicine released a report with a title that became a wake-up call for many in the field of oncology, From Cancer Patient to Cancer Survivor: Lost in Transition. A committee of 17 experts in the field set out to raise awareness of the consequences of having cancer and cancer treatments, to define a standard of healthcare quality for cancer survivors, and to determine how to implement that quality and to improve the quality of life of cancer survivors.
The hematology/oncology residency is typically a focused experience in which the trainees work to enrich their hematology/oncology knowledge and enhance their clinical skills.
Page 3 of 5
Results 21 - 30 of 42